The latest price target for Johnson & Johnson (NYSE:JNJ) was reported by Barclays on January 28, 2025. The analyst firm set a price target for $166.00 expecting JNJ to rise to within 12 months (a possible 9.17% upside). 53 analyst firms have reported ratings in the last year.

The latest analyst rating for Johnson & Johnson (NYSE:JNJ) was provided by Barclays, and Johnson & Johnson maintained their equal-weight rating.

The last upgrade for Johnson & Johnson happened on April 18, 2024 when HSBC raised their price target to $170. HSBC previously had a hold for Johnson & Johnson.

The last downgrade for Johnson & Johnson happened on July 23, 2024 when Daiwa Capital changed their price target from $160 to $150 for Johnson & Johnson.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Johnson & Johnson, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Johnson & Johnson was filed on January 28, 2025 so you should expect the next rating to be made available sometime around January 28, 2026.

While ratings are subjective and will change, the latest Johnson & Johnson (JNJ) rating was a maintained with a price target of $159.00 to $166.00. The current price Johnson & Johnson (JNJ) is trading at is $152.06, which is out of the analyst’s predicted range.